Sigrid Carlsson

Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Anssi Auvinen, Maciej Kwiatkowski, T. Tammela, 2012, European urology.

Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.

Andrew J Vickers, Hans Lilja, P. Scardino, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised study.

J. Hugosson, G. Aus, C. Wessman, 2007, European journal of cancer.

Overdetection in screening for prostate cancer

J. Hugosson, S. Carlsson, Jonas Hugosson, 2014, Current opinion in urology.

It ain't what you do, it's the way you do it: five golden rules for transforming prostate-specific antigen screening.

Hans Lilja, A. Vickers, H. Lilja, 2014, European urology.

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.

Erik Holmberg, Hans Lilja, Johan Stranne, 2010, The Lancet. Oncology.